维普中文期刊产品整合服务
20篇 您的检索式:作者名="BERROU J"
    题名 作者 年代 出处 被引量
1Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta 显示文摘Hertig A Berrou J Allory Y 2003FASEB J2003,17,13:1
2Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through over activation of transforming growth factor beta 显示文摘Hertig A Berrou J Allory Y 2003FASEB J2003,17,13:1
3A dvanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells显示文摘Berrou J Tostivint I Verrecehia F 2009Int J Mol Med2009,23,4:1
4Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells显示文摘Berrou J Tostivint I Verreechia F 2009Int J Mol Med2009,23,4:1
5Type Ⅰ plasmlnogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivafivation of transforming growth factor beta显示文摘HERTIG A BERROU J ALLORY Y 2003FASEBJ2003,17,13:1
6Type I plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overaetivafion of transforming growth factor beta 显示文摘Hertig A Berrou J Anory Y 2003FASEB J2003,17,13:1
7Effects of Ginkgo biloba extract on glucose transport and glycogen synthesis of cultured smooth muscle cells from pig aorta显示文摘Bruel A Gardette J Berrou E 1989Pharmacol Res1989,21,:1
8Effects of hy- pertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function= primary results of the observational study on cognitive function and systolic blood pressure reductionopenqabel study显示文摘Hanon O Berrou J P Negre Pages L 2008J Hypertens2008,26,8:1
9Effect of eprosar- tan-based therapy on systolic blood pressure and total cardio vascular risk in a large international population: preliminary report of the observational POWER study显示文摘Goudev A Berrou J P Pathak A 2012Vase Health Risk Manag2012,8,:1
10Naturalkiller cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes显示文摘Berrou J Fougeray S Venot M 2013PloS one2013,8,62:1
11Advanced glycation end products regulate extracellu larmatrix prote in and protease expression by human giome rular mesangial cells显示文摘Berrou J Tostivint I Verrechia F 2009Int J Mol Med2009,23,4:1
12The personal network of entre- preneurs in an informal African urban economy: Does the 'strength of ties' mater? 显示文摘Berrou J and Combarnous F 2002Review of Social Economy2002,70,1:1
13Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta 显示文摘Hertig A Berrou J Allory Y 2003The Faseb Journal2003,17,13:1
14Role of thrombin receptors in the kidney: lessons from PAR1 knock-out mice显示文摘Rondeau E Vigneau U Berrou J 2001Nephrol Dial Transplant2001,16,8:1
15Acute graft-versus-host disease transiently impairs thy- mic output in young patients after allogeneic hematopoietic stem cell transplantation 显示文摘Clave E Busson M Douay C Peffauh de Latour R Berrou J Rabian C 2009Blood2009,113,25:1
16Calibration and Validation of the Legion Simulation Model Using Empirical Data显示文摘Berrou J L Beecham J 2007Springer Berlin Heidelberg2007,28,6:1
17Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor-β显示文摘Hertig A Berrou J Allory Y 2003FASEB J2003,17,13:1
18Natural killer cell function an important target for infection and tumor protection is impaired in type 2 diabetes显示文摘Berrou J Fougeray S Venot M 2013PLoS One2013,8,62:1
19Natural killer cell func- tion an important target for infection and tumor protection is impaired in type 2 diabetes显示文摘Berrou J Fougeray S Venot M 2013PLoS One2013,8,62:1
20Advanced glycation end products regulate extracellular matrix protein and protease expres- sion by human glomerular mesangial cells 显示文摘Berrou J Tostiviut I Verrecchia F 2009lnt J Mol Med2009,23,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费